CS Genetics expands C-suite leadership
The private company has elevated Jay Harger to Chief Operating Officer and Mike Stubbington to Chief Scientific Officer as it transitions to full-throttle commercial operation and starts development of a large-scale single cell product pipeline.
Harger will be responsible for leading the company’s global operations strategy that will include facilities, manufacturing, supply chain and program management.
He joined CS in 2022 as Senior Vice President of Operations, prior to which he was at Illumina for over 15 years in a variety of senior leadership roles.
These included Senior Director of Product Management, where he oversaw Illumina’s core Library Prep strategy, and Senior Director of Portfolio Management, where he led program management and R & D support for Illumina’s entire $3.5 billion on-market product portfolio.
Stubbington will lead the company’s global research and development group and also serve as site head for the company’s UK operations at the Science Park.
He joined CS in 2023 as Vice President of Research and Development, prior to which he held a variety of roles both developing and applying single cell technologies.
This included his work at 10x Genomics, where he led development of the Barcode Enabled Antigen Mapping (BEAM) product line for applications in immunoprofiling and therapeutic discovery, and at the Wellcome Sanger Institute, where he led the Institute’s Human Cell Atlas (HCA) organisation.
CS Genetics has developed a next generation, instrument free platform for single cell genomics that leverages a molecular process known as Kinetic Confinement to produce simple, scalable, and accessible workflows that plug seamlessly into standard lab infrastructure.
The platform is forecast to expand the reach of single cell genomics to major, underserved segments such as new-to-single cell customers and biopharma – and significantly broaden the use of single cell as a tool for scientific discovery.
The company holds a large global intellectual property estate covering its single cell platform and related reagent, workflow, manufacturing and application technologies.